Globus Medical Sponsors NASS 2018, Hosts In-Booth Presentations on ExcelsiusGPS®
September 25 2018 - 5:37PM
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal
solutions company, will feature its ExcelsiusGPS® revolutionary
robotic guidance and navigation system along with its latest
advancements in expandable interbody technology at the North
American Spine Society (NASS) Annual Meeting being held September
26-29, 2018 in Los Angeles, CA.
Globus Medical’s participation at NASS includes two in-booth
presentations from surgeons currently using ExcelsiusGPS® that
highlight the versatility of robotic guidance and navigation in
both minimally invasive and complex deformity procedures. In
addition to the presentations, meeting attendees have the
opportunity to discuss advancements in robotic surgery and
experience the company’s most recent product innovations.
“As leaders in the musculoskeletal device industry, we are
committed to supporting the research, education, and development of
medical advancements through robotic spine surgery,”
said Chief Executive Officer Dave Demski. “We are proud to be
a sponsor of NASS and are excited to showcase the strong
utilization and clinical experience with our system just one year
after launch.”
Globus welcomes NASS attendees to case presentations in
Booth #1411.
Wednesday, September 26th, 3:15PM
Minimally Invasive Cases with ExcelsiusGPS® Sabino
D’Agostino, MD Charleston Brain and Spine, Charleston, SC
Thursday, September 27th, 3:15PM
Complex and Deformity Cases with ExcelsiusGPS®
Themistocles Protopsaltis, MD NYU Langone Health, New York, NY
About Globus Medical, Inc.Globus Medical, Inc.
is a leading musculoskeletal solutions company based in Audubon,
PA. The company was founded in 2003 by an experienced team of
professionals with a shared vision to create products that enable
surgeons to promote healing in patients with musculoskeletal
disorders. Additional information can be accessed
at http://www.globusmedical.com.
Safe Harbor StatementsAll statements included
in this press release other than statements of historical fact are
forward-looking statements and may be identified by their use of
words such as “believe,” “may,” “might,” “could,” “will,” “aim,”
“estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan”
and other similar terms. These forward-looking statements are based
on our current assumptions, expectations and estimates of future
events and trends. Forward-looking statements are only predictions
and are subject to many risks, uncertainties and other factors that
may affect our businesses and operations and could cause actual
results to differ materially from those predicted. These risks and
uncertainties include, but are not limited to, factors affecting
our quarterly results, our ability to manage our growth, our
ability to sustain our profitability, demand for our products, our
ability to compete successfully (including without limitation our
ability to convince surgeons to use our products and our ability to
attract and retain sales and other personnel), our ability to
rapidly develop and introduce new products, our ability to develop
and execute on successful business strategies, our ability to
successfully integrate the operations of Nemaris and retain key
employees, our ability to comply with changing laws and regulations
that are applicable to our businesses, our ability to safeguard our
intellectual property, our success in defending legal proceedings
brought against us, trends in the medical device industry, general
economic conditions, and other risks. For a discussion of these and
other risks, uncertainties and other factors that could affect our
results, you should refer to the disclosure contained in our most
recent annual report on Form 10-K filed with the Securities and
Exchange Commission, including the sections labeled “Risk Factors”
and “Cautionary Note Concerning Forward-Looking Statements,” and in
our Forms 10-Q, Forms 8-K and other filings with the Securities and
Exchange Commission. These documents are available at www.sec.gov.
Moreover, we operate in an evolving environment. New risk factors
and uncertainties emerge from time to time and it is not possible
for us to predict all risk factors and uncertainties, nor can we
assess the impact of all factors on its business or the extent to
which any factor, or combination of factors, may cause actual
results to differ materially from those contained in any
forward-looking statements. Given these risks and uncertainties,
readers are cautioned not to place undue reliance on any
forward-looking statements. Forward-looking statements contained in
this press release speak only as of the date of this press release.
We undertake no obligation to update any forward-looking statements
as a result of new information, events or circumstances or other
factors arising or coming to our attention after the date
hereof.
Contact:Brian KearnsVice President, Business
Development and Investor RelationsPhone: (610) 930-1800Email:
investors@globusmedical.comwww.globusmedical.com
Globus Medical (NYSE:GMED)
Historical Stock Chart
From Mar 2024 to Apr 2024
Globus Medical (NYSE:GMED)
Historical Stock Chart
From Apr 2023 to Apr 2024